Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice

This publication has 22 references indexed in Scilit:

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
  Annals of the Rheumatic Diseases, 2014
• Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
  Rheumatology, 2013
• Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
  Annals of the Rheumatic Diseases, 2013
• Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice
  Modern Rheumatology, 2012
• Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry
  Annals of the Rheumatic Diseases, 2011
• Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
  Arthritis Research & Therapy, 2011
• Treating rheumatoid arthritis to target: recommendations of an international task force
  Annals of the Rheumatic Diseases, 2010
• Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
  Reumatología Clínica, 2010
• Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
  Rheumatology International, 2009
• The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
  Arthritis & Rheumatism, 1988